Demandware® Inc. (NYSE:DWRE)
the industry-leading provider of enterprise cloud commerce solutions,
today announced that it has agreed to acquire Tomax, an enterprise cloud
software company that provides an integrated solution for retail
point-of-sale (POS) and store operations.
Hospitality Properties Trust (NYSE: HPT) today announced a regular
quarterly common share distribution of $0.49 per common share ($1.96 per
share per year). This distribution will be paid to HPT’s common
shareholders of record as of the close of business on January 23, 2015
and distributed on or about February 24, 2015.
Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), a leader in the development
of RNAi therapeutics, today announced the presentation of new
preclinical data on its Dicer substrate short interfering RNA (DsiRNA)
therapeutics targeting MYC and β-catenin (CTNNB1) oncogenes in
models of hepatocellular carcinoma (HCC) and colorectal cancer (CRC).
The positive data, presented during a poster session on January 9 at
MYC: From Biology to Therapy, a meeting of the American Association of
Cancer Research (AACR) in La Jolla, Calif., provide additional insights
into the parameters that impact the delivery and activity of DsiRNA
therapeutics utilizing Dicerna’s proprietary EnCore™ lipid nanoparticle
(LNP) technology in HCC and CRC tumor models.
CBRE Group, Inc. (NYSE:CBG) today announced that it has refinanced its
existing credit facilities by amending and restating its senior secured
credit agreement, which now provides for a five-year $2.6 billion
revolving credit facility and a five-year $500 million Tranche A term
Corporation (NYSE: NCR), the global leader in consumer transaction
technologies, announced today that Axfood, a leading Swedish grocery
retailer, has chosen innovative NCR point-of-sale (POS) and scanner
technology to engage and interact with customers more effectively and
help increase sales.
Cytori Therapeutics, Inc. (NASDAQ:CYTX) announced today that the Center
for Biologics Evaluation and Research (CBER), a division of the U.S.
Food and Drug Administration (FDA), has given final approval to its
application for an Investigational Device Exemption (IDE) to begin a
pivotal trial (the “STAR trial”) to evaluate Cytori Cell Therapy™ as a
potential treatment for impaired hand function in scleroderma.
First demonstration of relevant hydroxyprogesterone caproate levels following oral administration in pregnant women
Projected dose between 400 and 800 mg twice a day is expected to be comparable to marketed 250 mg weekly IM product
Relative bioavailabilities similar between pregnant and non-pregnant women
SALT LAKE CITY, Jan.
AmerisourceBergen (NYSE:ABC) and MWI Veterinary Supply, Inc.
(NASDAQ:MWIV) today announced that they have entered into a definitive
merger agreement for AmerisourceBergen to acquire MWI Veterinary Supply
(MWI), the leading animal health distribution company in the United
Sign-up for 2015/1/12 - UPDATE -- UPCOMING DEADLINE: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Nymox Pharmaceutical Corporation and Its Board of Directors and a Lead Plaintiff Deadline of January 26, 2015 -- NYMX investment picks
Amber Road, Inc. (NYSE: AMBR), a leading provider of global trade
management (GTM) solutions, today announced that it will report its
fourth quarter and full year 2014 financial results after the U.S.
financial markets close on Wednesday, February 11, 2015.
Labs (NASDAQ: SLAB), a leading provider of environmental and optical
sensing solutions for the Internet
of Things and industrial automation, today introduced a new family
of high-precision temperature sensors offering industry-leading power
Sign-up for 2015/1/12 - SHAREHOLDER ALERT: Brower Piven, a Maryland-Based Securities Litigation Law Firm, Announces Class Action Lawsuit in Connection With the Sale of Simplicity Bancorp, Inc. -- SMPL investment picks
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.